185 results
Page 5 of 10
8-K
EX-1.1
ept kawxke
13 Nov 20
First commercial orders completed, assay design based on proprietary ARESdb to comprehensively cover antibiotic resistance markers
4:52pm
8-K
EX-10.1
2ofam39
2 Nov 20
Departure of Directors or Certain Officers
4:33pm
8-K
86ujp5i ha0hg9z7336
2 Oct 20
Departure of Directors or Certain Officers
5:19pm
424B5
v2fue dbm
4 Sep 20
Prospectus supplement for primary offering
4:15pm
8-K
EX-99.1
hugkj6 ch7ac1
20 Aug 20
Regulation FD Disclosure
4:34pm
DEFA14A
45h2pr658x72sm lqf
20 Aug 20
Additional proxy soliciting materials
4:09pm
S-8
1zsfbb6tl9l ie
14 Aug 20
Registration of securities for employees
5:00pm
8-K
olxux 68oy
11 Aug 20
Departure of Directors or Certain Officers
4:10pm
8-K
EX-10.1
lgmjunv3j8763uzm
11 Aug 20
Departure of Directors or Certain Officers
4:10pm
8-K
EX-10.2
seufm iamygzx
11 Aug 20
Departure of Directors or Certain Officers
4:10pm
8-K/A
EX-99.1
k1bsq7 eqk7il8kuk9nh
15 Jun 20
Combined Statement of Operations and Other Comprehensive Loss
5:07pm
8-K
iam1dyrqh57s5g
7 May 20
OpGen Reports First Quarter 2020 Financial Results and Provides Business Update
4:38pm
8-K
EX-99.2
hpdfx6r
14 Apr 20
OpGen Announces Preliminary Unaudited Revenue and Cash Position for First Quarter 2020 and Provides Business Update
5:22pm
8-K
EX-10.6
2tmvbh
2 Apr 20
Completion of Acquisition or Disposition of Assets
5:30pm
8-K
EX-10.1
q009 lf3la
2 Apr 20
Completion of Acquisition or Disposition of Assets
5:30pm